Table 2. Spearman’s correlation analysis between C-IMT and clinical variables.
Variables | r | P |
---|---|---|
Age | 0.234 | <0.001 |
BMI | 0.110 | 0.001 |
W | 0.118 | <0.001 |
SBP | 0.224 | <0.001 |
DBP | 0.147 | <0.001 |
FPG | 0.093 | 0.004 |
2hPG | 0.047 | 0.155 |
HbA1c | –0.008 | 0.817 |
TC | –0.006 | 0.854 |
TG | 0.073 | 0.026 |
HDL-c | –0.064 | 0.053 |
LDL-c | –0.004 | 0.910 |
FINS | 0.107 | 0.001 |
HOMA-IR | 0.120 | <0.001 |
CRP | 0.063 | 0.056 |
25(OH)D3 | –0.113 | 0.001 |
Years since menopause | 0.151 | <0.001 |
Physical activity | –0.003 | 0.926 |
Smoking status | –0.003 | 0.919 |
Antidiabetic therapy | 0.039 | 0.238 |
Anti-hypertensives | 0.147 | <0.001 |
Lipid-lowering therapy | 0.130 | <0.001 |
Family history of CVD | 0.038 | 0.245 |
Abbreviation: C-IMT, carotid intima-media thickness; BMI, body mass index; W, waist circumference; SBP, systolic blood pressure; DBP, diastolic blood pressure; FPG, fasting plasma glucose; 2hPG, 2h postprandial plasma glucose; HbA1c, glycated hemoglobin A1c; TC, total cholesterol; TG, triglyceride; HDL-c, high-density lipoprotein cholesterol; LDL-c, low-density lipoprotein cholesterol; FINS, fasting insulin; HOMA-IR, homeostasis model assessment for insulin resistance; CRP, C-reactive protein; 25(OH)D3, 25 hydroxyvitamin D3; CVD, cardiovascular disease.